Investigating the impact of COVID-19 on performance and image enhancing drug use.
Anabolic–androgenic steroids
COVID-19
Exercise
Performance and image enhancing drug use
Steroids
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
04 12 2021
04 12 2021
Historique:
received:
26
07
2021
accepted:
15
11
2021
entrez:
5
12
2021
pubmed:
6
12
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Emerging research has suggested that the COVID-19 pandemic has had some impact on substance use patterns. The aim of the study was to conduct a rapid survey to assess the impact of COVID-19 on performance and image enhancing drug (PIED) use and training, and any subsequent negative physical or mental health outcomes. During 2020, a convenience sample of 60 PIED consumers (mean age = 26.69; 68.3% located outside Australia) completed a quantitative anonymous online survey exploring how the coronavirus pandemic impacted patterns of PIED use and associated exercise habits. The survey was administered via the Qualtrics platform and distributed online through PIED forums as well as through the investigators' networks. Participants were asked about their PIED use and exercise habits prior to and during restricted movement 'lockdowns'. During pre-COVID, the majority of the sample opted to 'blast-cruise' (an initial high dose, followed by a lower maintenance dose; 71.7%, n = 43). During lockdown, 45% (n = 27) reported a change in PIED use as a result of the restrictions. In light of health concerns during COVID-19, a majority of men (60%, n = 36) did not take any extra precautions relating to their PIED use. A subgroup of men ceased using PIEDs completely (16.7%, n = 10) with the majority (80%, n = 8) of that subgroup following post-cycle therapy (PCT) of some kind. Only a small proportion of the sample reported negative mental health issues as a result of PCT access issues. This study contributes to the emerging literature of the impact of the COVID-19 pandemic on substance use, specifically PIED use among men. The results suggest that the pandemic did influence the choice of PIEDs that participants consumed, although there was little disruption to patterns of exercise, an important aspect of PIED use. Of the men who did cease use completely, the majority reported little issue with PCT access; those who reported difficulty accessing PCT compounds indicated experience some mental health concerns related to ceasing their PIED use. Clinicians and those who come into contact with this group should be alert for any negative physical or mental health concerns resulting from disrupted or ceased PIED use.
Sections du résumé
BACKGROUND
Emerging research has suggested that the COVID-19 pandemic has had some impact on substance use patterns. The aim of the study was to conduct a rapid survey to assess the impact of COVID-19 on performance and image enhancing drug (PIED) use and training, and any subsequent negative physical or mental health outcomes.
METHODS
During 2020, a convenience sample of 60 PIED consumers (mean age = 26.69; 68.3% located outside Australia) completed a quantitative anonymous online survey exploring how the coronavirus pandemic impacted patterns of PIED use and associated exercise habits. The survey was administered via the Qualtrics platform and distributed online through PIED forums as well as through the investigators' networks. Participants were asked about their PIED use and exercise habits prior to and during restricted movement 'lockdowns'.
RESULTS
During pre-COVID, the majority of the sample opted to 'blast-cruise' (an initial high dose, followed by a lower maintenance dose; 71.7%, n = 43). During lockdown, 45% (n = 27) reported a change in PIED use as a result of the restrictions. In light of health concerns during COVID-19, a majority of men (60%, n = 36) did not take any extra precautions relating to their PIED use. A subgroup of men ceased using PIEDs completely (16.7%, n = 10) with the majority (80%, n = 8) of that subgroup following post-cycle therapy (PCT) of some kind. Only a small proportion of the sample reported negative mental health issues as a result of PCT access issues.
CONCLUSIONS
This study contributes to the emerging literature of the impact of the COVID-19 pandemic on substance use, specifically PIED use among men. The results suggest that the pandemic did influence the choice of PIEDs that participants consumed, although there was little disruption to patterns of exercise, an important aspect of PIED use. Of the men who did cease use completely, the majority reported little issue with PCT access; those who reported difficulty accessing PCT compounds indicated experience some mental health concerns related to ceasing their PIED use. Clinicians and those who come into contact with this group should be alert for any negative physical or mental health concerns resulting from disrupted or ceased PIED use.
Identifiants
pubmed: 34863199
doi: 10.1186/s12954-021-00571-8
pii: 10.1186/s12954-021-00571-8
pmc: PMC8642842
doi:
Substances chimiques
Performance-Enhancing Substances
0
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124Informations de copyright
© 2021. The Author(s).
Références
Drug Alcohol Rev. 2020 May;39(4):297-300
pubmed: 32445265
J Addict Med. 2021 Jun 17;:
pubmed: 34145186
Int J Drug Policy. 2020 Sep;83:102870
pubmed: 32741719
Sports Med. 2007;37(2):145-68
pubmed: 17241104
BMJ Case Rep. 2021 Feb 26;14(2):
pubmed: 33637513
Addiction. 2022 Jan;117(1):182-194
pubmed: 34159666
Front Psychol. 2016 Dec 21;7:1992
pubmed: 28066308
Int J Drug Policy. 2017 Feb;40:6-15
pubmed: 27574781
Drug Alcohol Depend. 2021 Apr 1;221:108580
pubmed: 33674175
Front Psychiatry. 2021 Mar 22;12:636706
pubmed: 33828494
Emerg Med Australas. 2020 Oct;32(5):901
pubmed: 32754975
Int J Drug Policy. 2020 Sep;83:102894
pubmed: 32741717
Front Psychiatry. 2021 Mar 10;12:648501
pubmed: 33776822
Front Psychiatry. 2020 Nov 27;11:602033
pubmed: 33329157